There were 539 press releases posted in the last 24 hours and 357,472 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
NLS-1 Pharma and Eurofarma Enter to an Exclusive Licensing Agreement to Develop and Commercialize Nolazol® for the Treatment of ADHD in Latin America

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image